0
0

Transparency in COVID–19 Vaccination Act

12/30/2022, 7:04 AM

Congressional Summary of S 2841

Transparency in COVID-19 Vaccination Act

This bill requires the Department of Health and Human Services to publicly disclose information about all adverse events that have arisen from COVID-19 vaccines, the statistical occurrence of such events, and adverse effects from clinical trials or other studies.

Current Status of Bill S 2841

Bill S 2841 is currently in the status of Bill Introduced since September 23, 2021. Bill S 2841 was introduced during Congress 117 and was introduced to the Senate on September 23, 2021.  Bill S 2841's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of September 23, 2021

Bipartisan Support of Bill S 2841

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
0
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2841

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health
- Emergency medical services and trauma care
- Government information and archives
- Health information and medical records
- Health promotion and preventive care
- Immunology and vaccination
- Infectious and parasitic diseases
- Medical research

Alternate Title(s) of Bill S 2841

Transparency in COVID–19 Vaccination Act
A bill to require the Secretary of Health and Human Services to publicly disclose information regarding adverse effects of COVID-19 vaccines.
Transparency in COVID–19 Vaccination Act

Comments